Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.

Clinical trial NCT04602754 · RECRUITING

Trial details

NCT number: NCT04602754
Sponsor: EMS
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Dyslipidemia Associated With Type II Diabetes Mellitus

Start date: 2023-12-01
Primary completion: 2026-05-01
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.